Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study

Abstract Background Despite trends towards the increased age of patients living with multiple sclerosis (MS), little is known about the response of older adults with MS to disease-modifying therapies (DMTs). Thus, a post-hoc analysis was undertaken using data from a 2-year, international, non-interv...

Full description

Bibliographic Details
Main Authors: Francesco Patti, Javier Nicolas Penaherrera, Lorissa Zieger, Eva-Maria Wicklein
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Disease-modifying therapies
Age
Interferon beta-1b
Online Access:https://doi.org/10.1186/s12883-021-02347-w

Similar Items

Similar Items